Key facts
- This page summarizes Karim Saad Temsamani's Form 4 filing for Cardlytics, Inc. (CDLX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jun 2024, 20:11.
Karim Saad Temsamani - 01 Jun 2024 Form 4 Insider Report for Cardlytics, Inc. (CDLX)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- CDLX
- Reported as of
- 01 Jun 2024
- Net transaction value
- -$373,281
- SEC form
- 4
- Accepted by SEC
- 04 Jun 2024, 20:11:11 UTC
- Prior SEC filing
- 02 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nick Lynton, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Karim Saad Temsamani filed Form 4 for Cardlytics, Inc. (CDLX) on 04 Jun 2024.
Change
- Previous filing in this sequence was filed on 02 Apr 2024.
- Current net transaction value: -$373,281.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDLX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +84,079
- Change %
- +24%
- Price
- Shares after
- 428,659
- Date
- 01 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
CDLX
transaction
Common Stock
Sale
- Transaction value
- $373,281
- Shares
- -43,129
- Change %
- -10%
- Price
- $8.66
- Shares after
- 385,530
- Date
- 04 Jun 2024
- Ownership
- Direct
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDLX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -84,079
- Change %
- -10%
- Price
- $0.000000
- Shares after
- 756,710
- Date
- 01 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 84,079
- Exercise price
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each RSU represents a contingent right to receive one share of common stock of the Issuer or, at the election of the Issuer, its cash equivalent.
Footnote F2
Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on June 1, 2024. The Reporting Person did not sell shares for any other purpose.
Footnote F3
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $8.55 to $8.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
Footnote F4
25% of the RSUs vested on September 1, 2023, with the remaining 75% having vested or vesting in equal amounts over the subsequent three years quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.